Laurent Billot

3

Articles

6

Comments
Evidence isn’t always as straightforward as it might first seem. Mai Lam/The Conversation NY-BD-CC

Trust Me, I’m An Expert: Brain‑zapping, the curious case of the n‑rays and other stories of evidence

Madeleine De Gabriele, The Conversation and Sunanda Creagh, The Conversation

Brain-zapping, the curious case of the n-rays and other stories of evidence The Conversation, CC BY70.4 MB (download)
You've had an x-ray before but have you had an n-ray? Of course not, because they're not real. But people used to think they were. Today, on Trust Me, I'm an Expert, we're bringing you stories on the theme of evidence.
A drug needs to pass quite a few hurdles before it gets to the market. The Conversation/Wes Mountain

Explainer: how do drugs get from the point of discovery to the pharmacy shelf?

Sabine Braat, The University of Melbourne; Elaine Mary Pascoe, The University of Queensland; Katherine J Lee, Murdoch Children's Research Institute, and Laurent Billot, UNSW

Only around 10% of new drugs in development make it onto the market. A drug needs to go through animal trials, and then four phases of human trials to be deemed suitable for use in patients.
Randomisation is the only commonly accepted method of ensuring an unbiased estimate of the treatment effect. The Conversation/Wes Mountain

Randomised control trials: what makes them the gold standard in medical research?

Katherine J Lee, Murdoch Children's Research Institute; Elaine Mary Pascoe, The University of Queensland; Laurent Billot, UNSW , and Sabine Braat, The University of Melbourne

A randomised controlled trial is the best way to compare a new treatment with the standard treatment. And randomising trial participants is a core feature of the experiment.

Contact Laurent for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision